Five Prime Therapeutics, Inc. FPRX
— —
Day range unavailable
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2020 · select a line to chart its full history
Income statement
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 13.18M | 14.87M | 49.87M | 39.51M | 30.69M | |
| 13.18M | 14.87M | 49.87M | 39.51M | 30.69M | |
| -92.87M | -141.94M | -146.16M | -151.40M | -99.21M | |
| -84.33M | -137.20M | -140.45M | -150.22M | -65.70M | |
| -2.29 | -3.92 | -4.13 | -5.38 | -2.44 |
Balance sheet
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 70.97M | 57.34M | 45.50M | 61.33M | 9.20M | |
| 331.65M | 224.14M | 321.53M | 344.05M | 448.28M | |
| 66.55M | 73.67M | 56.40M | 78.84M | 56.71M | |
| 47.43M | 49.61M | 0 | 0 | 0 | |
| 265.10M | 150.47M | 265.14M | 265.20M | 391.57M |
Cash flow
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| -64.65M | -113.87M | -122.51M | -112.18M | -79.75M | |
| -110.63M | 126.18M | -2.50M | 174.21M | -53.71M | |
| 188.91M | -463.00K | 109.17M | -9.89M | -8.85M | |
| 6.68M | -1.78M | -11.33M | -4.93M | -2.96M | |
| 13.62M | 11.85M | -15.84M | 52.14M | -142.32M |